Untreated XXXX in an emergency department @entity662 observation unit population.

@entity662 @entity1 @entity1007 @entity412 @entity165
OBJECTIVES: To describe the prevalence of @entity1007 in a predominantly African American, innercity @entity662 observation unit (CPOU) @entity1 population, and to estimate the percentage of @entity1 eligible for @entity165 -lowering therapy as indicated by the 2001 National @entity165 Education Program guidelines. METHODS: A cross-sectional study design utilizing a convenience sample of @entity1 from a high-volume urban hospital CPOU. @entity1 with @entity662 suspicious of cardiac etiology who had negative initial electrocardiograms and cardiac markers were assigned to the @entity662 protocol. Consenting subjects were screened for @entity1007 through capillary blood point-of-care testing with a cutoff of 190 mg/dL. Those who tested positive had four-hour fasting complete lipid profiles performed by the central laboratory. RESULTS: There were 112 @entity1 enrolled in this study (mean age = 51 years; 57% male; and 83% African American). Elevated values on the screening test were obtained on 28 [25%; 95% confidence interval (95% CI) = 16.9 to 33.0] of these @entity1 . These @entity1 were found to have a mean four-hour fasting total @entity165 level of 224 mg/dL, a low-density lipoprotein (LDL) level of 138 mg/dL, a high-density lipoprotein (HDL) level of 52 mg/dL, and a @entity412 level of 168 mg/dL. Of the @entity1 identified through the screening test, 54% proved eligible for @entity165 -lowering medications and 91.7% of these @entity1 reported an interest in initiating therapy. CONCLUSIONS: In this study, approximately 25% of inner-city CPOU @entity1 are possible candidates for @entity165 -lowering interventions. Benefits of initiating therapy during this potential "teachable moment" in a CPOU should be investigated in a subsequent multicenter randomized trial.
